{"id":"https://openalex.org/A5060078980","orcid":"https://orcid.org/0009-0004-6567-162X","observed_orcids":["https://orcid.org/0009-0004-6567-162X"],"display_name":"Kiyotoshi Kuramoto","raw_author_names":["Kiyotoshi Kuramoto"],"full_name":"Kiyotoshi Kuramoto","works_count":6,"cited_by_count":19,"summary_stats":{"2yr_mean_citedness":2.0,"h_index":3,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5060078980","orcid":"https://orcid.org/0009-0004-6567-162X","observed_orcids":["https://orcid.org/0009-0004-6567-162X"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210119256","ror":"https://ror.org/028gkfr23","display_name":"Kissei Pharmaceutical (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210119256"]},"years":[2026,2024,2021,2019]}],"last_known_institutions":[{"id":"https://openalex.org/I4210119256","ror":"https://ror.org/028gkfr23","display_name":"Kissei Pharmaceutical (Japan)","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210119256"]}],"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":5,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","count":3,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","count":3,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11967","display_name":"Electrolyte and hormonal disorders","count":2,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13569","display_name":"Microscopic Colitis","count":2,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T13569","display_name":"Microscopic Colitis","value":4.34e-05,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":1.97e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11967","display_name":"Electrolyte and hormonal disorders","value":1.55e-05,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","value":9.1e-06,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","value":6.4e-06,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9807000160217285},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.6432999968528748},{"id":"126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","score":0.6194319128990173},{"id":"197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","score":0.5081737041473389},{"id":"535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","score":0.4632999897003174}],"counts_by_year":[{"year":2019,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":1},{"year":2021,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":2},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":1},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":7},{"year":2026,"works_count":3,"oa_works_count":3,"cited_by_count":8}],"display_name_alternatives":["Kiyotoshi Kuramoto"],"block_key":"k kuramoto","works_api_url":"https://api.openalex.org/works?filter=author.id:A5060078980","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5060078980","updated_date":"2026-11-10T14:30:39","created_date":"2019-01-11T00:00:00"}